MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

China Cord Blood Corp Company Profile (NYSE:CO)

Consensus Ratings for China Cord Blood Corp (NYSE:CO) (?)
Ratings Breakdown: 3 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Hold (Score: 2.40)
Consensus Price Target: $9.13 (58.70% upside)

Analysts' Ratings History for China Cord Blood Corp (NYSE:CO)
Show:
DateFirmActionRatingPrice TargetActions
2/6/2016ScotiabankReiterated RatingSector PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/5/2016Howard WeilDowngradeOutperform -> Sector PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/25/2015Roth CapitalReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/6/2015Credit SuisseReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/10/2015Jefferies GroupReiterated RatingBuy$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/30/2014 forward)
Earnings History for China Cord Blood Corp (NYSE:CO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/17/2016        
6/14/2016Q416$0.03$0.03$24.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/29/2016Q316$0.04$0.10$27.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/23/2015Q216$0.04$0.04$26.42 million$27.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/19/2015Q116$0.04$0.03$25.81 million$26.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
6/18/2015Q415$0.05$0.04$25.88 million$26.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2015Q315$0.06$0.07$26.35 million$26.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/25/2014Q2$0.06$0.06ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/28/2014Q1$0.05$0.06$24.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
6/18/2014Q414$0.07$0.07ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2014Q3$0.06$0.07$24.22 million$24.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/31/2014Q4($0.25)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/15/2013Q2$0.06$0.06$22.32 million$23.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/26/2013Q1 2014$0.04$0.07$21.62 million$21.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
6/18/2013Q4 2013$0.02$0.05$16.59 million$21.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/19/2012Q312$0.05$18.53 million$20.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for China Cord Blood Corp (NYSE:CO)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.03$0.03$0.03
Q1 20171$0.03$0.03$0.03
Q2 20171$0.04$0.04$0.04
Q3 20171$0.05$0.05$0.05
Q4 20171$0.05$0.05$0.05
(Data provided by Zacks Investment Research)
Dividend History for China Cord Blood Corp (NYSE:CO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for China Cord Blood Corp (NYSE:CO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
1/21/2015Kent C MccarthyInsiderBuy20,000$4.60$92,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/16/2015Kent C MccarthyInsiderBuy50,000$4.30$215,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/14/2015Private Equity Fund Jayhawk IIInsiderBuy10,000$4.52$45,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/12/2015Private Equity Fund Jayhawk IIInsiderBuy50,000$4.69$234,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/28/2014Robert Douglas CudneyInsiderBuy200,000$0.01$1,000.00Tweet This Trade  Share This Trade on StockTwits
11/17/2014Kent C MccarthyInsiderBuy26,754$4.70$125,743.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/6/2014Kent C MccarthyInsiderBuy150,000$5.16$774,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/29/2014Kent C MccarthyInsiderBuy10,000$5.00$50,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2014Kent C MccarthyInsiderBuy9,900$4.98$49,302.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for China Cord Blood Corp (NYSE:CO)
DateHeadline
06/28/16 01:59 PMChina Cord Blood Corp. :CO-US: Earnings Analysis: Q4, 2016 By the Numbers : June 28, 2016 -
06/28/16 08:13 AMBroker Outlook For The Week Ahead China Cord Blood Corporation (NYSE:CO) - Fiscal Standard
06/27/16 07:53 AMStrong Sell Calls Recommendations For China Cord Blood Corporation (NYSE:CO) At 0 - Investor Newswire
06/25/16 07:13 AMChina Cord Blood Corporation versus CorVel Corporation Head to Head Compare - CML News
06/24/16 07:03 AMCivitas Solutions, Inc. versus China Cord Blood Corporation Head to Head Compare - CML News
06/23/16 09:49 AMChina Cord Blood Corporation (NYSE:CO) Updated Price Targets - FTSE News
06/21/16 03:11 PMRevenue Update on China Cord Blood Corp(NYSE:CO) - Trade Calls
06/19/16 03:08 PMStrong Buy Calls Count For China Cord Blood Corporation (NYSE:CO) At 0 - Investor Newswire
06/19/16 03:08 PMChina Cord Blood Corporation (NYSE:CO) Analyst Price Targets For The Coming Week - Fiscal Standard
06/18/16 07:55 AMBRIEF-Nanjing Xinjiekou Department Store to acquire stkae in China Cord Blood Corp - Reuters
06/17/16 03:35 AMBRIEF-Nanjing Xinjiekou Department Store to acquire stkae in China Cord Blood Corp - * Says it plans to acquire 65.4 percent stake in China Cord Blood Corp for 5.8 billion yuan ($880.46 million) via cash, share issue
06/16/16 03:17 PMChina Cord Blood Corporation: China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2016
06/16/16 03:17 PMChina Cord Blood Corporation (CO) Q4 2016 Results - Earnings Call Transcript
06/15/16 03:23 PMBRIEF-China Cord Blood Corp reports Q4 earnings per share $0.03 - Reuters
06/15/16 03:23 PMChina Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2016 - PR Newswire (press release)
06/15/16 03:23 PMChina Cord Blood Corporation (CO) Q4 2016 Results - Earnings Call Transcript - Seeking Alpha
06/15/16 08:06 AMChina Cord Blood Corp Q4 Earnings Drop 51%
06/15/16 08:06 AMBRIEF-China Cord Blood Corp reports Q4 earnings per share $0.03
06/15/16 08:06 AMChina Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2016
06/14/16 07:38 AMThese Companies Are Set to Report Their Earnings Today
06/14/16 07:38 AMChina Cord Blood Corp Earnings Call (Q4 2016)
06/14/16 06:07 AMQ4 2016 China Cord Blood Corp Earnings Release - After Market Close -
06/09/16 09:22 PMTrend Of Rating Given To China Cord Blood Corporation (NYSE:CO) - Investor Newswire
06/08/16 03:52 PMCHINA CORD BLOOD CORPORATION (NYSE:CO) Financial Condition Compared to S&P 500 - CML News
06/07/16 11:39 AMChina Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2016 Financial Results - PR Newswire (press release)
06/07/16 05:58 AMChina Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2016 Financial Results - [at noodls] - b87ef600-4a5f-4b54-a952-fae7d1726c36.pdf Earnings Call Scheduled for 8:00 a.m. ET on June 15, 2016 HONG KONG, China, June 7, 2016 - China Cord Blood Corporation (NYSE: CO) (the "Company") today ...
06/05/16 03:14 PMNext Weeks Broker Price Targets For China Cord Blood Corporation (NYSE:CO) - Share Trading News
06/02/16 09:21 PMChina Cord Blood Corporation (NYSE:CO) Change In Inventory At $-0.332 Millions - RealistInvestor.com - China Cord Blood Corporation (NYSE:CO) Change In Inventory At $-0.332 MillionsRealistInvestor.comChina Cord Blood Corporation (NYSE:CO) accounts payable was $2.044 millions for the fiscal closed 2015-03-31. For the quarter ended 2015-03-31 it was $2.044 millions. At the end of the year 2015-03-31, the deviation in accounts payable was $0.363 ...
05/17/16 07:39 AMChina Cord Blood Corp. breached its 50 day moving average in a Bearish Manner : CO-US : May 17, 2016 -
04/09/16 01:30 PMChina Cord Blood Corporation (NYSE:CO) Updated Broker Price Targets - Share Trading News - China Cord Blood Corporation (NYSE:CO) Updated Broker Price TargetsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of China Cord Blood Corporation (NYSE:CO). The latest reports which are currently in issue on Thursday 7th of April state 0 analysts have a rating of “strong buy”, 0 ...
04/09/16 01:30 PMChina Cord Blood Corporation (NYSE:CO) Updated Analyst Coverage - Risers & Fallers - China Cord Blood Corporation (NYSE:CO) Updated Analyst CoverageRisers & FallersA number of investment brokers have recently updated their price targets on shares of China Cord Blood Corporation (NYSE:CO). According to the latest broker reports outstanding on Friday 8th of April, 0 analysts have a rating of “strong buy”, 0 ...
04/05/16 02:44 PMUPDATE: Jayhawk Capital Offers Open Letter to Special Committee of China Cord Blood Board - The following is an open letter sent April 5, 2016 to the Board of Directors of China Cord Blood Corp (NYSE: CO) from Jayhawk Capital. It is clear that the Board should accept a privatization offer only if ALL shareholders will receive the same $15+ per share ($6.40 in cash and $8.68 in Nanjiang Xinjiekou Department Store Co., Ltd. ("NXD") shares) at which Golden Meditech Holdings Co Ltd ("Golden Med") has agreed to sell its stake. China Cord Blood Corp ("China Cord" or the "Company") should be negotiating directly with NXD and no longer allow Golden Med to be the go-between whose sole intent is to take all the profit for itself. The pattern of taking value away from shareholders of China Cord has become standard practice. Consider the convertible bonds issued in 2012 to KKR and then to Golden Med at low prices, thus diluting the existing minority shareholders. The proceeds from the bonds were never needed or used, and the bonds ultimately eliminated $525 million of value for China Cord shareholders (based on the value Golden Med is receiving for them from NXD). Consider too the share-based incentive compensation for management adopted by the Company in December 2014 whereby nearly 10% of the outstanding shares of China Cord are to be awarded for hitting modest growth targets management was already expected to meet. Golden Med has announced plans to vest these shares immediately as part of the NXD transaction, despite only being one year in and despite even those modest incentive goals not being reached. This will cost shareholders over $100 million (7,080,000 shares x ~$15 per share). Self-interested transactions like these must stop immediately. However, the privatization effort by Golden Med is clearly another disaster waiting to happen for China Cord's minority shareholders. China Cord has been performing strongly and is expected to continue to do so as the effect of the Chinese Government relaxing the one-child policy begins to be felt more dramatically. China Cord is generating cash of approximately ...Full story available on Benzinga.com
04/05/16 01:21 PMApril 5, 2016 Open Letter to the Special Committee of the Board of China Cord Blood Corp from Jayhawk Capital - [PR Newswire] - NEW YORK, April 5, 2016 /PRNewswire/ -- The following is an open letter sent April 5, 2016 to the Board of Directors of China Cord Blood Corp (CO) from Jayhawk Capital. It is clear that the Board should accept a privatization offer only if ALL shareholders will receive the same $15+ per share ($6.40 in cash and $8.68 in Nanjiang Xinjiekou Department Store Co., Ltd. ("NXD") shares) at which Golden Meditech Holdings Co Ltd ("Golden Med") has agreed to sell its stake. China Cord Blood Corp ("China Cord" or the "Company") should be negotiating directly with NXD and no longer allow Golden Med to be the go-between whose sole intent is to take all the profit for itself.
03/16/16 12:14 PMChina Cord Blood Corp. – Value Analysis (NYSE:CO) : March 16, 2016 -
03/15/16 12:14 PMGlobal Cord Blood Banking Services Market Hampered by Blood Shortage and Restrictive Usage; Market to Reach US $15.23 Bn by 2019 - Inc., China Cord Blood Corporation, ViaCord, Inc., Cord Blood Registry Systems, Inc., and Cord Blood America, Inc. Key segments of the Global Cord Blood Banking Services Market
03/15/16 07:10 AMChina Cord Blood Corp. breached its 50 day moving average in a Bullish Manner : CO-US : March 15, 2016 -
03/04/16 03:56 PMChina Cord Blood Corp. :CO-US: Earnings Analysis: Q3, 2016 By the Numbers -
02/29/16 03:29 PMChina Cord Blood posts 3Q profit -
02/29/16 03:16 PMChina Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2016 - [PR Newswire] - HONG KONG, March 1, 2016 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic ...
02/29/16 06:07 AMQ3 2016 China Cord Blood Corp Earnings Release - After Market Close -
02/28/16 01:20 PMAnalysis and China Cord Blood Corp (CO) Earnings Review - OctaFinance.com - Analysis and China Cord Blood Corp (CO) Earnings ReviewOctaFinance.comAnalysts await China Cord Blood Corp (NYSE:CO) to reports earnings on February, 29 after the close. They expect $0.05 earnings per share, down 28.57 % or $0.02 from last year's $0.07 per share. CO's profit will be $3.98 million for 29.35 P/E if the $0 ...
02/22/16 01:43 PMChina Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2016 Financial Results - PR Newswire (press release) - China Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2016 Financial ResultsPR Newswire (press release)HONG KONG, Feb. 22, 2016 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release financial results for the third quarter and first nine months of fiscal year 2016 on Monday, February 29, 2016, ...China Cord Blood Corp (CO) to Release Earnings on TuesdayFinancial Market Newsall 5 news articles »
02/22/16 06:00 AMChina Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2016 Financial Results - [PR Newswire] - HONG KONG, Feb. 22, 2016 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release financial results for the third quarter and first nine ...
02/12/16 12:32 PMCordlife swings into the black on non-operating gains - The company sold shares in China Cord Blood Corp and convertible notes issued by China Cord Blood during the quarter. Those transactions led to Cordlife recognising fair value gains on its investment in China Cord Blood, including a S$7.3 million gain on ...
02/10/16 12:28 PMScotia Howard Weil Downgrades China Cord Blood Corp to Sector Perform - Street Edition - Scotia Howard Weil Downgrades China Cord Blood Corp to Sector PerformStreet EditionBrokerage firm Scotia Howard Weil Downgrades its rating on China Cord Blood Corp(NYSE:CO). The shares have been rated Sector Perform. Previously, the analysts had a Outperform rating on the shares. The rating by Scotia Howard Weil was issued on ...
02/02/16 11:16 AMRecent Broker Updates On China Cord Blood Corporation (NYSE:CO) - Risers & Fallers - Recent Broker Updates On China Cord Blood Corporation (NYSE:CO)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of China Cord Blood Corporation (NYSE:CO). The latest broker reports which are currently outstanding on Tuesday 2nd February state 1 analyst has a rating of “strong buy”, ...
01/28/16 06:05 PMChina Cord Blood Enters Oversold Territory (CO) - A stock is considered to be oversold if the RSI reading falls below 30. In trading on Thursday, shares of China Cord Blood Corp (CO) entered into oversold territory, hitting an RSI reading of 29.6, after changing hands as low as $5.87 per share.
12/08/15 01:38 AMShould You Buy China Cord Blood Corp (CO)? -
11/24/15 07:00 AMChina Cord Blood Corp Earnings Call scheduled for 8:00 am ET today -
11/23/15 03:40 PMChina Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2016 - [at noodls] - a5ae960c-fa38-4df7-a43e-08f9f96b8fd4.pdf 2Q16 Added 16,744 New Subscribers 2Q16 Revenue Up 12.7% YOY to RMB171.5 Million ($27.0 Million) 2Q16 Operating Income Amounted to RMB52.5 Million ($8.3 Million) ...
About China Cord Blood Corp

China Cord Blood Corp logoChina Cord Blood Corporation is principally engaged in the provision of umbilical cord blood storage and ancillary services in the People's Republic of China. The Company provides cord blood testing, processing and storage services under the direction of subscribers. The Company also preserves cord blood units donated by the public, provides matching services on such donated units and delivers matching units to patients in need of transplants. The Company's cord blood banking operations primarily consist of its subscription services, which involve the preservation of cord blood for expectant parents as a precautionary healthcare measure for the benefit of their children and other family members. Its subscription services consist of the collection of the newborn's cord blood unit at one of its collaborating hospitals and the transportation of the cord blood unit to one of its facilities for testing and processing and the long-term storage of the cord blood unit at the facility.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: CO
  • CUSIP:
Key Metrics:
  • Previous Close: $5.75
  • 50 Day Moving Average: $5.96
  • 200 Day Moving Average: $6.06
  • P/E Ratio: 30.42
  • P/E Growth: 1.15
  • Market Cap: $419.77M
  • Current Quarter EPS Consensus Estimate: $0.17 EPS
Additional Links:
China Cord Blood Corp (NYSE:CO) Chart for Thursday, June, 30, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha